Deubikitinaasi USPX9/SolusykliCDC123 -akseli edistää rintasyöpääj säätelemällä solusykliä.

 

. 2023 Oct;62(10):1487-1503.

doi: 10.1002/mc.23591. Epub 2023 Jun 14.

USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle

Nan Song  ¹ , Ling Deng  ¹ , Lijie Zeng  ¹ , Li He  ¹ , Chunyan Liu  ¹ , Ling Liu  ¹ , Rong Fu  ¹

Affiliations

• PMID: 37314216
• DOI: 10.1002/mc.23591

Abstract

Cell division cycle 123 (CDC123) has been implicated in a variety of human diseases. However, it remains unclear whether CDC123 plays a role in tumorigenesis and how its abundance is regulated. In this study, we found that CDC123 was highly expressed in breast cancer cells, and its high expression was positively correlated with a poor prognosis. Knowndown of CDC123 impaired the proliferation of breast cancer cells. Mechanistically, we identified a deubiquitinase, ubiquitin-specific peptidase 9, X-linked (USP9X), that could physically interact with and deubiquitinate K48-linked ubiquitinated CDC123 at the K308 site. Therefore, the expression of CDC123 was positively correlated with USP9X in breast cancer cells. In addition, we found that deletion of either USP9X or CDC123 led to altered expression of cell cycle-related genes and resulted in the accumulation of cells population in the G0/G1 phase, thereby suppressing cell proliferation. Treatment with the deubiquitinase inhibitor of USP9X, WP1130 (Degrasyn, a small molecule compound that USP9X deubiquitinase inhibitor), also led to the accumulation of breast cancer cells in the G0/G1 phase, but this effect could be rescued by overexpression of CDC123. Furthermore, our study revealed that the USP9X/CDC123 axis promotes the occurrence and development of breast cancer through regulating the cell cycle, and suggests that it may be a potential target for breast cancer intervention. In conclusion, our study demonstrates that USP9X is a key regulator of CDC123, providing a novel pathway for the maintenance of CDC123 abundance in cells, and supports USP9X/CDC123 as a potential target for breast cancer intervention through regulating the cell cycle.

Keywords: CDC123; USP9X; breast cancer; deubiquitination; protein stability.

© 2023 The Authors. Molecular Carcinogenesis published by Wiley Periodicals LLC.

PubMed Disclaimer

Similar articles

• Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.

  Lu Q, Lu D, Shao ZM, Li DQ. Cancer Sci. 2019 Apr;110(4):1268-1278. doi: 10.1111/cas.13953. Epub 2019 Feb 21. PMID: 30689267 Free PMC article.Collectively, these findings indicate that USP9X is a stabilizer of RNF115 protein and that the USP9X-RNF115 signaling axis is implicated in the breast cancer malignant phenotype.
• USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.

  Shang Z, Zhao J, Zhang Q, Cao C, Tian S, Zhang K, Liu L, Shi L, Yu N, Yang S. J Biol Chem. 2019 Jun 21;294(25):9844-9857. doi: 10.1074/jbc.RA119.007655. Epub 2019 May 9. PMID: 31073027 Free PMC article.
• USP9X regulates centrosome duplication and promotes breast carcinogenesis.

  Li X, Song N, Liu L, Liu X, Ding X, Song X, Yang S, Shan L, Zhou X, Su D, Wang Y, Zhang Q, Cao C, Ma S, Yu N, Yang F, Wang Y, Yao Z, Shang Y, Shi L. Nat Commun. 2017 Mar 31;8:14866. doi: 10.1038/ncomms14866. PMID: 28361952 Free PMC article.